Boundless Bio Inc
For the period ended Mar 31, 2024. Filed May 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 13, 2024
BOLD$2.45-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Convertible Preferred Stock and Stockholders’ Deficit
(in thousands, except share data)
| Convertible Preferred Stock · Common Stock · Accumulatedother · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Additionalpaid-in-capital · comprehensiveincome/ (loss) · Accumulateddeficit · stockholders’deficit | |||||||||
| Balance at December 31, 2023 | 287,446,844 | $247,617 | 1,247,012 | $ | - | $8,987 | $40 | $(136,109) | $(127,082) |
| Vesting of early exercised stock options | — | — | 522 | — | 2 | — | — | 2 | |
| Exercise of stock options | — | — | 15,104 | — | 59 | — | — | 59 | |
| Stock-based compensation | — | — | — | — | 1,328 | — | — | 1,328 | |
| Unrealized loss on short-term investments | — | — | — | — | — | (61) | — | (61) | |
| Net loss | — | — | — | — | — | — | (15,430) | (15,430) | |
| Balance at March 31, 2024 | 287,446,844 | $247,617 | 1,262,638 | $ | - | $10,376 | $(21) | $(151,539) | $(141,184) |
| Balance at December 31, 2022 | 144,589,706 | $147,946 | 1,167,240 | $ | - | $5,377 | $(398) | $(86,675) | (81,696) |
| Vesting of early exercised stock options | — | — | 17,505 | — | 52 | — | — | 52 | |
| Exercise of stock options | — | — | 9,195 | — | 31 | — | — | 31 | |
| Stock-based compensation | — | — | — | — | 615 | — | — | 615 | |
| Unrealized gain on short-term investments | — | — | — | — | — | 278 | — | 278 | |
| Net loss | — | — | — | — | — | — | (11,719) | (11,719) | |
| Balance at March 31, 2023 | 144,589,706 | $147,946 | 1,193,940 | $ | - | $6,075 | $(120) | $(98,394) | $(92,439) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.